Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 6

Perkütan mitral balon valvüloplastinin akut ve uzun dönem takip sonuçları: Tek merkez çalışması

Acute and long-term follow-up results of percutaneous mitral balloon valvuloplasty: a single-center study

Pages
515–520
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Those 63 patients were subclassified into two groups as those without any negative event (n=26) (Group 1) and those with mitral valve area (MVA) (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Percutaneous mitral balloon valvuloplasty (PMBV) is the method of choice in treatment of patients with hemodynamically significant mitral stenosis.
📊
Key Findings & Data:Methods: In this retrospective cohort study; 311 patients who underwent PMBV in our Cardiology Clinic at Türkiye Yüksek İhtisas Education and Research Hospital between January 2000 and March 2004 were evaluated for acute procedural outcomes and primary endpoints (death, rePMBV, mitral valve replacement (MVR)).
💡
Conclusion & Impact:Those 63 patients were subclassified into two groups as those without any negative event (n=26) (Group 1) and those with mitral valve area (MVA) (
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Percutaneous mitral balloon valvuloplasty (PMBV) is the method of choice in treatment of patients with hemodynamically significant mitral stenosis. We aimed to analyze acute and long-term clinical and echocardiographic consequences of PMBV. Methods: In this retrospective cohort study; 311 patients who underwent PMBV in our Cardiology Clinic at Türkiye Yüksek İhtisas Education and Research Hospital between January 2000 and March 2004 were evaluated for acute procedural outcomes and primary endpoints (death, rePMBV, mitral valve replacement (MVR)). All 311 patients were contacted by phone call or letter at least five years after the procedure. Of the 311 patients, 87 who defined NYHA class II-IV symptoms were invited for a control visit and detailed echocardiographic evaluation. Sixty-three patients out of 87 who completed follow-up were enrolled for long-term consequences. Those 63 patients were subclassified into two groups as those without any negative event (n=26) (Group 1) and those with mitral valve area (MVA) (

Özet

Amaç: Perkütan mitral balon valvüloplasti (PMBV) hemodinamik olarak, ciddi mitral darlıklı hastaların tedavisinde tercih edilen yöntemdir. Biz PMBV’nin akut ve uzun dönem klinik ve ekokardiyografik sonuçlarını analiz etmeyi amaçladık. Yöntemler: Bu retrospektif kohort çalışmada Ocak 2000-Mart 2004 tarihleri arasında Türkiye Yüksek İhtisas Hastanesi, Kardiyoloji Kliniğinde, PMBV uygulanan 311 hasta, akut sonuçlar ve primer son noktalar [ölüm, yeniden PMBV, mitral kapak replasmanı (MKR)] yönünden değerlendirildi. Bu 311 hastanın tümüne işlemden en az 5 yıl sonra olmak üzere telefon ya da mektupla ulaşıldı. New York Heart Association (NYHA) sınıf 2-4 semptom tarifleyen 87 hasta kontrol vizite ve detaylı ekokardiyografik inceleme için davet edildi. Takibe gelen 87 hastanın 63’ünde uzun dönem sonuçlar değerlendirildi. Altmış üç hasta ortalama 6.4±1.6 yıllık takipte olaysız olanlar (26 hasta) (Grup 1) ve mitral kapak alanı (MKA)

🔖

Cite This Article

AKSU, T., DEMİRKAN, B., YILMAZ, M. B., GÜRAY, Y., ŞAŞMAZ, H., KORKMAZ, Ş. (2022). Perkütan mitral balon valvüloplastinin akut ve uzun dönem takip sonuçları: Tek merkez çalışması. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 6, 515–520. https://ajindex.com/articles/436410

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Inoue K, Owaki T, Nakamura F, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984; 87: 394-402
  2. Vahanian A, Michel PL, Cormier B, Vitoux B, Michel X, Slama M, et al. Results of percutaneous mitral commissurotomy in 200 patients. Am J Cardiol 1989; 63: 847-52
  3. Multicenter experience with balloon mitral commissurotomy. NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results. The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants. Circulation 1992; 85: 448-61
  4. Cohen DJ, Kuntz RE, Gordon SP, Piana RN, Safian RD, McKay RG, et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med 1992; 327: 1329-35
  5. Iung B, Garbarz E, Michaud P, Helou S, Farah B, Berdah P, et al. Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation 1999; 99: 3272-8
  6. Abascal VM, Wilkins GT, O’Shea JP, Choong CY, Palacios IF, Thomas JD, et al. Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy. Circulation 1990; 82: 448-56
  7. Palacios IF, Block PC, Wilkins GT, Weyman AE. Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. Circulation 1989; 79: 573-9
  8. Nobuyoshi M, Hamasaki N, Kimura T, Nosaka H, Yokoi H, Yasumoto H, et al. Indications, complications, and short-term clinical outcome of percutaneous transvenous mitral commissurotomy. Circulation 1989; 80: 782-92
  9. Meneveau N, Schiele F, Seronde MF, Breton V, Gupta S, Bernard Y, et al. Predictors of event-free survival after percutaneous mitral commissurotomy. Heart 1998; 80: 359-64
  10. Hernandez R, Banuelos C, Alfonso F, Goicolea J, Fernandez-Ortiz A, Escaned J, et al. Long-term clinical and echocardiographic followup after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation 1999; 99: 1580-6
  11. Kang DH, Park SW, Song JK, Kim HS, Hong MK, Kim JJ, et al. Longterm clinical and echocardiographic outcome of percutaneous mitral valvuloplasty: randomized comparison of Inoue and doubleballoon techniques. J Am Coll Cardiol 2000; 35: 169-75
  12. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvulo